OA
WeChat
Home
About Us
Investor Relations
R & D
Careers
Contact Us
Investor Relations
Corporate Information
Business Overview
Board of Directors,Senior Management and Academic Advisers
Corporate Governance
Financial Information
Shareholdings of Directors and CEO
Financial Reports
Stock Information
Corporate Communications
Announcements & Circulars
Returns on Share Capital
Multimedia
Corporate Presentation
Video
Corporate Pictures
Contact Us
Location:
>
Home
>
Inverstor Relations
>
Corporate Communications
>
Announcements & Circulars
You will need the Adobe Acrobat Reader 7.0 and Asian Font Packs to view the PDF.
If you do not have any of the above, please download
"Acrobat Reader"
and
"Asian Font Packs for Acrobat Reader 7.0"
.
Please select year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2022-01-26
(1) DISCLOSEABLE TRANSACTION-DISPOSAL OF EQUITY INTERESTS IN THE TARGET COMPANY; (2) UPDATE ON GAIN ON PREVIOUS DISPOSAL
2021-12-22
UPDATE ON JOINT VENTURE COMPANY-EARLY COMPLETION OF PATIENT ENROLLMENT OF EBRONUCIMAB (PCSK9 MONOCLONAL ANTIBODY, AK102) IN A PHASE III CLINICAL TRIAL FOR PRIMARY HYPERCHOLESTEROLEMIA AND MIXED HYPERL
2021-09-23
BUSINESS UPDATE-PRODUCT COOPERATION AGREEMENTS
2021-09-09
BUSINESS UPDATE- INITIATION OF PHASE III CLINICAL TRIAL FOR PRIMARY HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA OF AK102 AND INCREASE IN CAPITAL CONTRIBUTION IN JOINT VENTURE
2021-08-27
Interim Dividend for the year ending 31 December 2021 and Closure of Register of Members
2021-08-27
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021
2021-08-16
DATE OF BOARD MEETING
2021-07-30
BUSINESS UPDATE-DISPOSAL OF INTEREST IN A SUBSIDIARY
2021-05-28
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2021
2021-04-19
Form of proxy for use at the Annual General Meeting of the Company to be held on Friday, 28 May 2021 (or at any adjournment thereof)
Total
29
pages
Current
6
/
29
First
Prev
Next
Last
GO